TI
AMRX icon

Tidal Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Tidal Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
22,809
+5,288
+30% +$71K ﹤0.01% 2062
2025
Q4 		$221K Buy
+17,521
New +$200K ﹤0.01% 1973
2022
Q4 		– Sell
-10,540
Closed -$21K – 1108
2022
Q3 		$21K Buy
+10,540
New +$29.5K ﹤0.01% 1083

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Tidal Investments's AMRX Position: Q1 2026 in Review

Tidal Investments increased its Amneal Pharmaceuticals (AMRX) stake by 30% in Q1 2026, buying an estimated $71K and bringing the position to 22,809 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Tidal Investments first reported a position in AMRX in Q3 2022 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Tidal Investments held 22,809 shares of Amneal Pharmaceuticals worth $284K as of Q1 2026.
  • Tidal Investments bought 5,288 Amneal Pharmaceuticals shares in Q1 2026, an estimated $71K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #2062 holding.
  • Tidal Investments first reported a position in Amneal Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.